Refinery rail project would ease crude oil supply concerns
By Patrick Kulp / Friday, November 1st, 2013 / Central Coast, Technology, Top Stories, Tri-County Economy / Comments Off on Refinery rail project would ease crude oil supply concerns
A Phillips 66 refinery on the Nipomo Mesa is hoping to supplement its dwindling inflow of California crude by extending a rail spur that will allow it to import oil from out of state.
The refinery — tucked away off of Highway 1 in South San Luis Obispo County — is a little-known yet critical part of the Golden State’s petroleum infrastructure. It processes the state’s heavy, sour crude into semi-refined products that flow through 200 miles of pipeline to Conoco’s 128,000-barrel-a-day facility in Rodeo in the Bay Area, where it is turned into gasoline.
Read More →Energy efficiency firms snag $5M
By Staff Report / Wednesday, October 30th, 2013 / Latest news, Technology / Comments Off on Energy efficiency firms snag $5M
The U.S. Department of Energy has awarded $5 million to semiconductor and lighting companies in the region.
UC Santa Barbara, Buellton-based SixPoint Materials and Soraa were the recipients of money from the department.
Read More →Mindbody breaks ground on $20M campus in SLO tech corridor
By Staff Report / Tuesday, October 29th, 2013 / Central Coast, Latest news, Real Estate, Technology, Top Stories / Comments Off on Mindbody breaks ground on $20M campus in SLO tech corridor
San Luis Obispo is set to get its flagship high-tech campus as software company MindBody CEO Rick Stollmeyer and local officials broke ground Oct. 29 on a $20 million project including a new office building, four-story parking structure and promenade that will link with an existing facility, eventually boosting employment to 1,300 people.
Read More →Gov. Brown vetoes Amgen-backed anti-biosimilars bill
By Stephen Nellis / Friday, October 18th, 2013 / Banking & Finance, Central Coast Health Watch, Technology, Top Stories, Tourism, Tri-County Public Companies / Comments Off on Gov. Brown vetoes Amgen-backed anti-biosimilars bill
Gov. Jerry Brown vetoed a bill supported by Thousand Oaks-based Amgen and other biotechnology companies that would have made it more difficult for pharmacists to dispense so-called biosimilars, the biotech industry’s analogue to generic pharmaceuticals.
Senate Bill 598, approved by both houses of the legislature, looked mostly like a procedural change to state’s pharmacy laws. If it passed, the bill would have allowed pharmacists to fill prescriptions with biosimilars that the U.S. Food and Drug Administration deems “interchangeable” with brand-name counterparts.
Read More →The art of advertising: PureClick keeps an eye on Google
By Stephen Nellis / Friday, October 18th, 2013 / Features, Technology / Comments Off on The art of advertising: PureClick keeps an eye on Google
Internet veteran Tim Rodgers founded PureClick with a simple goal. Google’s display advertising networks offer to place banners and ads on thousands of websites across the Internet, playing a sort of matchmaker by putting those ads next to what it deems to be the most relevant content. PureClick aims to let advertisers double-check Google’s work.
Read More →RingRevenue dials up new software focus
By Staff Report / Friday, October 18th, 2013 / Technology, Top Stories / Comments Off on RingRevenue dials up new software focus
RingRevenue, the region’s fastest-growing company last year, has rebranded itself with a focus on its marketing software for corporate customers and added an executive from Salesforce.com’s acquisition team to its board of directors.
The Santa Barbara company’s new name will be Invoca. The firm makes a software platform that lets marketers insert unique telephone numbers into campaigns and then filter, track and give credit for incoming calls.
Read More →Stellar’s $12M raise sets stage for drug rollout
By Stephen Nellis / Friday, October 11th, 2013 / Technology, Top Stories / Comments Off on Stellar’s $12M raise sets stage for drug rollout
Port Hueneme-based Stellar Biotechnologies has closed a $12 million round of financing and acquired a license for what could one day be its first drug. Stellar gained notoriety in the research world by snatching up a facility inside the Port of Hueneme gates during a round of base closings in the late 1990s. It used Read More →
Read More →Popular articles
- None Found
Sponsored content:
SHIPS SLOW TO PROTECT WHALES, BLUE SKIES
-
Sign up for email news
Get the Business Times in your inbox. Sign up for breaking news alerts, our weekly briefing, and more.Sign upFor Email Marketing you can trust.2015-2016 Giving Guide
Check out our 2015 Giving Guide special issue